In order to show that CD46 plays decisive role in species B adenoviral gene therapy for CD46-overexpressing colon cancers, we developed chimeric Ad5/35 vectors with fiber knobs from Ad35 to specifically target CD46 in cancer cells. Here, CD46 is linked to malignant colon neoplasm.